Top Primary Biliary Cholangitis Therapeutics Companies, Leaders & Major Players

This list of the top companies of Primary Biliary Cholangitis Therapeutics is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Primary Biliary Cholangitis Therapeutics sector.

Top Primary Biliary Cholangitis Therapeutics Companies

  1. Abbvie

  2. Glenmark Pharmaceuticals

  3. Intercept Pharmaceuticals

  4. Teva Pharmaceutical Industries

  5. Viatris (Mylan)

*Disclaimer: Top companies sorted in no particular order

Primary Biliary Cholangitis Therapeutics Market Major Players

Primary Biliary Cholangitis Therapeutics - Competitive Concentration

Primary Biliary Cholangitis Therapeutics Market Concentration

List of Primary Biliary Cholangitis Therapeutics Companies

  • Intercept Pharmaceuticals

  • Teva Pharmaceutical Industries

  • Viatris (Mylan)

  • Ipsen (pharma)

  • Genfit

  • CymaBay Therapeutics

  • Dr Falk Pharma

  • Albireo (now Ipsen)

  • Mirum Pharmaceuticals

  • Gilead Sciences

  • Novartis

  • Zydus LifeSciences

  • Dr Reddy’s Laboratories

  • Pfizer

  • Johnson & Johnson

  • Abbvie

  • Endo International

  • Glenmark Pharmaceuticals

  • Sumitomo Dainippon Pharma

  • Eli Lilly and Company

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds